vaginal flora of hiv-infected women.

NLM AIDSLINE Vaginal flora of HIV-infected women. Giraldo PC; Daniel-Ribeiro AF; Simoes JA; Amaral E; State University of
January 30, 1997

Int Conf AIDS. 1996 Jul 7-12;11(1):164 (abstract no. Mo.C.1637). Unique Objective: To compare the prevalence of Vaginal Candidiasis, Vaginal Trichomoniasis and Bacterial Vaginosis among HIV+ women, women with AIDS and HIV- women under risk of HIV infection. Methods: A hundred and fifty two women (75 HIV- (group A), 46 HIV+ (group B) and 31 with AIDS (group C) who attended a STD outpatient clinic at State University of Campinas (SP-Brazil) in 1995 were included in this study. All patients went under a gynecological exam when a vaginal smear was obtained for a gram study. Data from gynecological exam and laboratory results were stored and analyzed by Chi-square or Fisher exact tests. Results: Trichomoniasis was found in 4,0% in group, A, 8,7% in group B and 19,3% in group C. Statistic analysis showed significant difference between groups A and C (p= 0,017) but no difference between groups A and B (p= 0,247) or B and C (p= 0,154). Candidiasis was registered in 17,3% of patients in group A, 21,7% in group B and 29,0% in group C, but there was no statistical differences between them (p is greater than 0,1). Bacterial vaginosis was found in 32% of group A, 36,9% in group B and 29,0% in group C and there was no difference among them (p is greater than 0,1). Conclusions: The initial hypothesis of greater prevalence of Candidiasis among AIDS women was not statistically confirmed in this study despite the observed tendency to that. On the other hand a higher prevalence of Trichomoniasis among patients with AIDS may confirm the idea of a greatness in vaginal flora of patients with advanced disease. This may be due not only to the clinical stage of the disease but also to the high drug therapy these patients are usually taking. Candidiasis, Vulvovaginal/COMPLICATIONS HIV Infections/COMPLICATIONS Trichomonas Infections/COMPLICATIONS Vagina/MICROBIOLOGY *Vaginosis, Bacterial/COMPLICATIONS

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Photographs from A Day with HIV Now Online Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 CANADA: Health Officials in St. John's N.L., Inform 50 People of Tuberculosis Risk OHIO: Cleveland LGBT Community Center Offers Free Support Groups and HIV, STD Testing: The Frugal Patient CALIFORNIA: Local Church Sends HIV/AIDS Care Packs to Swaziland NEVADA: Clinics Offer Low-Cost Care for those Lacking Insurance CONNECTICUT: At Hartford Public High School, A Day Reserved for 'Healthy Relationships' ITALY: HIV Is No Barrier to Successful Liver Transplant for Cancer Treatment KENYA: Kenya Launches Universal HPV Vaccine Access to Youths UNITED STATES: Navajo Confront an Increase in New H.I.V. Infections Uganda: HIV Vaccine Trials to Start in July Uganda: Remembering Those Killed By HIV/AIDS (International AIDS Candlelight Memorial) OHIO: Cleveland LGBT Community Center Offers Free Support Groups and HIV, STD Testing: The Frugal Patient CALIFORNIA: Local Church Sends HIV/AIDS Care Packs to Swaziland ITALY: HIV Is No Barrier to Successful Liver Transplant for Cancer Treatment UNITED STATES: Navajo Confront an Increase in New H.I.V. Infections Uganda: HIV Vaccine Trials to Start in July Uganda: Remembering Those Killed By HIV/AIDS (International AIDS Candlelight Memorial)Navajo Confront an Increase in New H.I.V. Infections TB, HIV and malaria vaccine research gets major boost Measuring hidden HIV 'Gap' for HIV vaccine efforts after latest setback
Information in this article was accurate in January 30, 1997. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.